Castle Biosciences Inc (CSTL) SEC Filings — 2024
17 SEC filings for Castle Biosciences Inc (CSTL) in 2024.
Filings
- Castle Biosciences Inc SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Castle Biosciences Inc SC 13G/A Filing — SC 13G/A · Nov 13, 2024
- Castle Biosciences Files Q3 2024 10-Q — 10-Q · Nov 4, 2024
- Castle Biosciences Files Q2 2024 10-Q — 10-Q · Aug 5, 2024
- Castle Biosciences Inc SC 13G/A Filing — SC 13G/A · Jul 8, 2024
- Castle Biosciences Reports on Shareholder Vote Outcome — 8-K · May 24, 2024
- Castle Biosciences Files Proxy Statement Update — DEFA14A · May 10, 2024
- Castle Biosciences Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 2, 2024
- Castle Biosciences, Inc. 2024 Annual Meeting of Stockholders Proxy Statement — DEF 14A · Apr 10, 2024
- Castle Biosciences Appoints New Chief Medical Officer — 8-K · Mar 27, 2024
- Castle Biosciences Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 28, 2024
- Castle Biosciences Inc SC 13G Filing — SC 13G · Feb 14, 2024
- Castle Biosciences Inc SC 13G Filing — SC 13G · Feb 13, 2024
- Castle Biosciences Inc SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Wasatch Advisors LP Holds 9.6% Stake in Castle Biosciences — SC 13G/A · Feb 9, 2024
- BlackRock Amends Castle Biosciences Stake to 9.2% — SC 13G/A · Jan 25, 2024
- Castle Biosciences Files 8-K on Financial Condition & Operations — 8-K · Jan 8, 2024